Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × sapanisertib × 30 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1

Interventions

trametinib 2 dabrafenib 2 pembrolizumab 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡